You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mucl-CART

Showing 1 - 25 of 267
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Acute Myeloid Leukemia(AML) Trial in Guangdong (CART therapy in Acute myeloid leukemia(AML))

Terminated
  • Relapsed/Refractory Acute Myeloid Leukemia(AML)
  • CART therapy in Acute myeloid leukemia(AML)
  • Guangdong, Guangdong, China
    Southern Medical University Zhujiang Hospital
Sep 5, 2021

B-All, Acute Lymphoblastic Leukemia Trial run by the National Cancer Institute (NCI) (NGS testing)

Not yet recruiting
  • B-All
  • Acute Lymphoblastic Leukemia
  • NGS testing
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Wuhu (CEA-targeted CAR-T cells)

Recruiting
  • Gastric Cancer
  • +7 more
  • CEA-targeted CAR-T cells
  • Wuhu, Anhui, China
    The First Affiliated Hospital of Wannan Medical College
Nov 9, 2023

Blood Pressure, Hypertension, Hypotension Trial in Gyeonggi-do (CART-I plus)

Completed
  • Blood Pressure
  • +2 more
  • CART-I plus
  • Gyeonggi-do, Pangyo, Korea, Republic of
    Sky Labs
Feb 2, 2023

Study for Patients Treat With WU-CART-007

Enrolling by invitation
  • T-cell Acute Lymphoblastic Leukemia
  • T-cell Lymphoblastic Lymphoma
  • Genetic: WU-CART-007
  • Saint Louis, Missouri
    Washington University
Aug 18, 2022

Multiple Myeloma Trial in Boston, Milwaukee (CART-ddBCMA)

Not yet recruiting
  • Multiple Myeloma
  • CART-ddBCMA
  • Boston, Massachusetts
  • +1 more
Jul 7, 2022

Large B-cell Lymphoma, B-cell Lymphoma Trial in Houston (Magrolimab, Rituximab, CAR T leukapheresis)

Not yet recruiting
  • Large B-cell Lymphoma
  • B-cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2023

Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

Not yet recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • GC012F
  • (no location specified)
Apr 28, 2023

Multiple Myeloma Trial in Philadelphia (CART-19 cells)

Terminated
Has Results
  • Multiple Myeloma
  • CART-19 cells
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 4, 2023

NSCLC, Ovarian Cancer, Fallopian Tube Cancer Trial in United States (CART-TnMUC1, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • CART-TnMUC1
  • +2 more
  • Phoenix, Arizona
  • +9 more
Jul 18, 2022

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

Recruiting
  • Multiple Myeloma
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 12, 2023

T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

Not yet recruiting
  • T-Cell Non-Hodgkin Lymphoma
  • +14 more
  • WU-CART-007
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Pancreatic Cancer Trial in Shanghai (U87 CAR-T)

Recruiting
  • Pancreatic Cancer
  • U87 CAR-T
  • Shanghai, China
    China Shanghai 10th People's Hospital
Oct 29, 2022

ACLs Learning Trial in Tainan (An ACLs cart training course was developed using augmented reality (AR) technologies)

Completed
  • ACLs Learning
  • An ACLs cart training course was developed using augmented reality (AR) technologies
  • Tainan, no-US, Taiwan
    Wan-Na Sun
Sep 20, 2023

HIV-1-infection Trial in Puerto Rico, United States (TMB-365/TMB-380)

Recruiting
  • HIV-1-infection
  • San Francisco, California
  • +6 more
Oct 25, 2022

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 13, 2023

Castrate-Resistant Prostate Cancer Trial in Shanghai (LIGHT-PSMA-CART cells)

Suspended
  • Castrate-Resistant Prostate Cancer
  • LIGHT-PSMA-CART cells
  • Shanghai, Shanghai, China
    Changhai Hospital
Jan 25, 2023

Prostate Cancer Trial in Beijing (CART-PSMA cells)

Recruiting
  • Prostate Cancer
  • CART-PSMA cells
  • Beijing, China
    Chinese PLA General Hospital
Dec 12, 2022

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Bone Marrow Aspiration
  • +10 more
  • Los Angeles, California
    Melanie Ayala Ceja
Jul 10, 2023

Multiple Myeloma Trial in Nantong (Colchicine, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nantong, Jiangsu, China
    Affiliated Hospital of Nantong University
Mar 25, 2023

Renal Cell Carcinoma, Adrenal Tumor, Nonfunctioning Kidney Trial (telesurgery by domestic surgical robot)

Not yet recruiting
  • Renal Cell Carcinoma
  • +13 more
  • telesurgery by domestic surgical robot
  • (no location specified)
Feb 12, 2023

Solid Tumor Trial (HER2-E-CART cells)

Not yet recruiting
  • Solid Tumor
  • HER2-E-CART cells
  • (no location specified)
Feb 16, 2023

SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy

Recruiting
  • Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)
  • COVID-19 serology IgG
  • Detroit, Michigan
    Henry Ford Health System
Jul 19, 2022

Leukemia, Lymphoma, Cardiotoxicity Trial in Philadelphia

Completed
  • Leukemia
  • +4 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jan 19, 2023

    B-cell Lymphoma Trial in Hangzhou (PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells)

    Active, not recruiting
    • B-cell Lymphoma
    • PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, Zhejiang University School of Med
    Sep 28, 2022